Adaptimmune Therapeutics Plc Adr (ADAP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Adaptimmune Therapeutics Plc Adr Azioni (ADAP) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	126.10% 7.285	3.222	40.90	128.23	5.678
Cost Of Revenue	0.879	-	-	-	-
Gross Profit	6.406	-	-	-	-
Operating Expenses	32.00% 52.14	76.67	55.58	59.53	54.94
Benefits Costs and Expenses	28.32% 54.29	75.74	57.69	58.18	53.66
Costs And Expenses	30.91% 53.02	76.74	55.58	59.53	54.94
Operating Income/Loss	37.79% -45.73	-73.52	-14.68	68.70	-49.26
Income/Loss From Continuing Operations Before Tax	35.18% -47.01	-72.52	-16.79	70.05	-47.98
Income Tax Expense/Benefit	66.04% 0.575	1.693	0.831	0.526	0.526
Income/Loss From Continuing Operations After Tax	35.88% -47.58	-74.22	-17.62	69.52	-48.50
Net Income/Loss	35.88% -47.58	-74.22	-17.62	69.52	-48.50
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	21,184% 1,542.16	7.2456	1,534.61	1,533.53	1,451.24
Diluted Average Shares	6,744% 1,542.16	-23.21	1,534.61	1,559.18	1,451.24
Basic Earnings Per Share	40.00% -0.03	-0.05	-0.01	0.05	-0.03
Diluted Earnings Per Share	40.00% -0.03	-0.05	-0.01	0.04	-0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$85.44

1.75%

GMAB

$27.38

1.11%

SMMT

$23.80

1.19%

BNTX

$103.50

3.07%

INSM

$142.53

0.68%

ONC

$318.73

5.21%